AB0209 PHYSICIAN TRUST RATHER THAN RHEUMATOID ARTHRITIS KNOWLEDGE RELEVANT IN DISEASE OUTCOMES IN ETHNIC MINORITY PATIENTS WITH RHEUMATOID ARTHRITIS release_4rjuf2svdbf3rm7nrch4numqsq

by S. Dowell, M. Quinones, A. Miller, O. Kadiri, T. Jamshidi, G. Kerr

Published in Annals of the Rheumatic Diseases by BMJ.

2022   Volume 81, Issue Suppl 1, p1233.1-1233

Abstract

<jats:sec><jats:title>Background</jats:title>Ethnic minority (EM) patients with Rheumatoid Arthritis (RA) have more severe disease, more disability, and less use of biologic disease modifying anti-rheumatic drugs (bDMARDs). A Treat to target (T2T) strategy has been recommended to improve clinical outcomes but barriers include patient preference, access to specialty care and increased administrative effort. Additionally, EM patients in the US often have low health literacy, express greater reluctance to accept physician recommendations, in part due to sociocultural preference and mistrust of a historically biased healthcare system. It is unknown whether improving knowledge of RA would improve T2T outcomes in EM active RA patients.</jats:sec><jats:sec><jats:title>Objectives</jats:title>To assess the proportion of EM RA patients who achieve low disease activity or remission following implementation of a coordinator-based education program highlighting T2T RA strategy.</jats:sec><jats:sec><jats:title>Methods</jats:title>Adult participants with active RA (RAPID3&gt;6 or CDAI &gt; 10) were invited to participate in a series of five one-on-one 20-minute educational sessions, co-occurring with scheduled routine clinic visits (6 -12-week intervals). Sessions were facilitated by a rheumatology care coordinator, a non-healthcare professional with intensive training over 4 weeks to conduct RA patient education. Sociodemographic data was collected, and disease activity measures (TJC, SJC, RAPID3, CDAI) and validated patient questionnaires on RA Knowledge (ACREU), compliance (CQR5), and physician trust (Trust in Physician Scale) were recorded at baseline and after the final educational session. Descriptive statistics were applied and medians and ranges for instrument scores are reported. Paired T-test was used to test for significant differences in scores after the education sessions. Correlations between the ACREU scores and clinical-demographic variables were measured using Pearson's correlation coefficient.</jats:sec><jats:sec><jats:title>Results</jats:title>20 EM patients (75% Female, mean age, 58.8 years (12.2) seen by EM physicians were enrolled, with mean RA disease duration of 7 years and poor prognosticators (75% double seropositivity). ACREU scores were low at baseline (mean 0.45 (0.16)), with no significant improvement on completion of educational sessions, and no correlation with years of education or duration of RA. There was a positive correlation between ACREU and compliance scores at baseline (r=0.3). Average duration of the education period was 9.72 months, with a 33% decrease in average RAPID3 over time, and 42% of patients achieving a target of remission or LDA. Trust in Physician scores were high at baseline and persisted with &gt;50% of patients completing at least one medication change during study period.</jats:sec><jats:sec><jats:title>Conclusion</jats:title>RA knowledge did not impact RA patient outcomes in this cohort of EM patients. However, patients had high trust in their providers and achieved clinical remission or LDA despite risk for poor outcomes highlighting the importance of the provider- patient relationship in achieving targeted goals of therapy. Limitations include the small sample size from a single institution, and the lengthy time between initial and final assessment of RA knowledge.</jats:sec><jats:sec><jats:title>References</jats:title>[1]Lineker SC, Badley EM, Hughes EA, Bell MJ. Development of an instrument to measure knowledge in individuals with rheumatoid arthritis: the ACREU rheumatoid arthritis knowledge questionnaire. <jats:italic>The Journal of rheumatology</jats:italic>. 1997/04// 1997;24(4):647-653.[2]Hughes LD, Done J, Young A. A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. <jats:italic>BMC Musculoskeletal Disorders</jats:italic>. 2013-12-01 2013;14(1):286. doi:10.1186/1471-2474-14-286[3]Anderson LA, Dedrick RF. Development of the Trust in Physician Scale: A Measure to Assess Interpersonal Trust in Patient-Physician Relationships. <jats:italic>Psychological Reports</jats:italic>. 1990-12-01 1990;67(3_suppl):1091-1100. doi:10.2466/pr0.1990.67.3f.1091</jats:sec><jats:sec><jats:title>Acknowledgements</jats:title>Sincere gratitude to our patients for their participation, and to the team at Bristol Myers Squibb for supporting this research initiative.</jats:sec><jats:sec><jats:title>Disclosure of Interests</jats:title>Sharon Dowell Speakers bureau: Horizon Pharma, Aurinia Pharmaceuticals Inc, Abbvie, Grant/research support from: Pfizer, Bristol Myers Squibb, Mercedes Quinones Speakers bureau: Abbvie, Sanofi Genzyme, Grant/research support from: Bristol Myers Squibb, Pfizer, Alani Miller: None declared, Oshoze Kadiri: None declared, Tahereh Jamshidi: None declared, Gail Kerr Speakers bureau: Aurinia Pharmaceuticals Inc, Consultant of: CSL Behring, Janssen, Pfizer, Samumed, UCB, Viela Bio/Horizon, Grant/research support from: Novartis</jats:sec>
In application/xml+jats format

Archived Files and Locations

application/pdf   199.7 kB
file_z4izmfyrcfh7rk4o7alxsawq3a
ard.bmj.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-05-23
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0003-4967
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 2e1c000f-a682-4646-b8dd-5c84354965f3
API URL: JSON